Release Date: 23/02/18 13:16 Summary: PGC Preliminary Half Year Results to 31 December 2017 Price Sensitive: Yes Download Document 93.38KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status